Facebook
Twitter
LinkedIn
ForwardWebcast - Seattle Multidisciplinary Lung Cancer Conference
This accredited continuing education activity “Seattle Multidisciplinary Lung Cancer Conference," is recorded from the live oncology conference held on 10/23/2021 at the Crowne Plaza Downtown Seattle.
If you participated in the live oncology conference titled - Seattle Multidisciplinary Lung Cancer Conference on 10/23/2021 and claimed CME credits/MOC points for that activity, you do not qualify for CME credits/MOC points for your participation in this enduring activity. This is a recorded content from that live meeting on 10/23/2021. However, you may enroll in this activity to review the contents.
This accredited continuing education activity “Webcast - Seattle Multidisciplinary Lung Cancer Conference," features lectures and discussions presented by leading experts in lung cancer who provide a comprehensive overview of recent advances and controversies in the management of lung cancer.
The goal of this continuing education activity is to improve the knowledge, competence and performance of learners so that they can apply practice-changing clinical data and expert recommendations to optimize clinical outcomes for their patients with lung cancer.
In addition to expert faculty presenting key abstract findings from 2021 ASCO Annual Meeting (ASCO2021) and the IASLC 2021 World Conference on Lung Cancer (WCLC2021) into clinical context, faculties present clinical cases and discuss how the results might change the current standard of care for lung cancer patients.
REGISTRATION FEES:
This activity is free for all healthcare providers who are not employees of an ineligible entity. Please select "non-industry learner" when you are ready to register for the course, and the price will reset to $0.
Healthcare providers ($0.00)
Industry employees ($200 + 3% Credit card fee)
If you are a healthcare provider involved in patient care and you are not employed by the Industry, then you don't pay anything to register for this activity.
If you are employed by industry, you must pay a registration fee to participate in these meetings. Any unpaid industry registrations will be invoiced $412 per participant.
If you paid to join the live meeting associated with this webcast and wish to register for this enduring material please contact us and we will register you for free.
Target Audience
- Oncologists
- Oncology fellows
- Oncology nurses
- Oncology nurse practitioners
- Oncology physician assistants
- Oncology pharmacists
Learning Objectives
After participating in this enduring continuing education activity, participants will be able to:
- Review potentially practice changing abstracts presented at 2021 ASCO Annual Meeting (ASCO2021) and the IASLC 2021 World Conference on Lung Cancer (WCLC2021)
- Discuss the study design and primary endpoints of recently reported and ongoing trials that have influenced the changes in standards of care in lung cancer
- Compare and contrast the safety and efficacy profiles of novel therapeutic strategies that impact management of patients with lung cancer
- Integrate emerging evidence into treatment paradigms for treatment of lung cancer.
This educational activity features recorded videos from the live conference titled - Seattle Multidisciplinary Lung Cancer Conference held on 10/23/2021.
The videos are placed in the following order. Feel free to view the content that is relevant to you.
Participants should claim continuing education credits to the extent of their participation.
Session 1: Diagnosis/Next generation sequencing
Moderator: Dr. Andrea Veatch
25 minutes: Precision oncology – best practices in tissue/blood testing Dr. Tejas Patil
26 minutes: Detection & Clinical Application of Minimal Residual Disease in Lung Cancer Dr. Jack West
25 minutes: Pathologic assessment of NSCLC after neoadjuvant therapy Dr. Haodong Xu
20 minutes: Case-based Discussion Dr. Andrea Veatch
Session 2: Resectable non-small cell lung cancer
Moderator: Dr. Joseph Rosales
20 minutes: Sublobar resection in NSCLC Dr. Madhan Kuppusamy
22 minutes: Beyond chemotherapy – adjuvant targeted therapy in NSCLC Dr. Sandip Patel
20 minutes: Checkpoint inhibitors in neoadjuvant/adjuvant role in NSCLC Dr. Christina Baik
36 minutes: Case-based discussion Dr. Joseph Rosales/Dr. Jed Gorden
Session 3: Unresectable/metastatic non-small cell lung carcinoma
Moderator: Dr. John Paul Flores
17 minutes: Molecular directed therapy of advanced NSCLC in 2021 Dr. Kathryn Gold
17 minutes: Antibody-drug conjugates in NSCLC Dr. Rafael Santana-Davila
15 minutes: Emerging biomarker targets for checkpoint inhibitor therapy Dr. Wade T. Iams
40 minutes: Case-based Discussion Dr. Jaideep Shenoi/Dr. John Paul Flores
Session 4: Small cell lung carcinoma/mesothelioma
Moderator: Dr. Joseph Rosales
20 minutes: Surgery vs radiation in early-stage small cell lung cancer Dr. Adam Bograd
26 minutes: Immunotherapy and targeted therapy in small cell lung cancer Dr. Renato G. Martins
30 minutes: Pulmonary neuroendocrine tumors - recent updates Dr. Aman Chauhan
20 minutes: Case-based discussion Dr. Joseph Rosales
TEJAS PATIL, MD Assistant Professor Medicine University of Colorado Hospital | MADHAN KUPPUSAMY, MD, FRCS Thoracic Surgery Virginia Mason Medical Center | ANDREA VEATCH, MD Hematologist/Oncologist Northwest Medical Specialties Puyallup | Assistant Professor of Medicine Vanderbilt University Medical Center |
JOSEPH ROSALES, MD Oncologist Virginia Mason Medical Center | Thoracic Surgeon Swedish Issaquah Hospital | Pulmonologist Swedish Medical Center | JED GORDEN, MD Pulmonologist Swedish Medical Center |
JACK WEST, MD Medical Oncologist City of Hope Comprehensive Cancer Center | YOSHIO INOUE, MD Medical Oncology The Everett Clinic - Providence Regional Cancer Partnership | AMAN CHAUHAN, MD Assistant Professor of Medicine UK Markey Cancer Center | HAODONG XU, MD, PhD Professor University of Washington School of Medicine |
SANDIP PATEL, MD Medical Oncologist Associate Professor of Medicine Moores Cancer Center at UC San Diego Health | KATE GOLD, MD Medical Oncologist Associate Professor of Medicine Moores Cancer Center at UC San Diego Health |
|
|
CHRISTINA BAIK, MD, MPH Physician Seattle Cancer Care Alliance Associate Professor, Medicine University of Washington School of Medicine Associate Professor, Clinical Research Division Fred Hutchinson Cancer Research Center | Medical Director, Infusion and Pharmacy Services Seattle Cancer Care Alliance Associate Professor, Medicine and Oncology University of Washington School of Medicine Physician UW Medicine Associate Professor, Clinical Research Division Fred Hutchinson Cancer Research Center |
Important Information about Claiming CME for this activity:
If you participated in the live conference titled - Seattle Multidisciplinary Lung Cancer Conference on 10/23/2021 and claimed CME credits/MOC points for that activity, you do not qualify for CME credits/MOC points for your participation in this enduring activity. This is a recorded content from that live meeting on 10/23/2021. However, you can still enroll in this activity and review the contents as needed.
ACKNOWLEDGMENT OF COMMERCIAL SUPPORT
The live portion of this activity and any associated enduring content has been supported with independent medical education grant(s) from the following companies:
- Pfizer, Inc.
- AstraZeneca
- Regeneron
- Exact Sciences
- Jazz Pharmaceuticals
Available Credit
- 6.25 ABIM MOC IISuccessful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 6.25 Medical Knowledge points in the American Board of Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
- 6.25 AMA PRA Category 1 Credit™The Binaytara Foundation is accredited by the Washington State Medical Association to provide continuing medical education for physicians. The Binaytara Foundation designates this live activity for a maximum of 6.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This activity meets the criteria for up to 6.25 hours of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission.
- 6.25 Nursing Contact HoursProvider approved by the California Board of Registered Nursing, Provider # CEP17035, for 6.25 Contact Hours.
Price
REGISTRATION FEES:
This activity is free for all healthcare providers who are not employees of an ineligible entity. Please select "non-industry learner" when you are ready to register for the course, and the price will reset to $0.
Healthcare providers ($0.00)
Industry employees ($200 + 3% Credit card fee)
If you are a healthcare provider involved in patient care and you are not employed by the Industry, register for free!
If you are employed by industry, you must pay a registration fee to participate in these meetings. Any unpaid industry registrations will be invoiced $412 per participant.
If you paid to join the live meeting and wish to register for this enduring material please contact us and we will register you for free.
Cancellation Policy
You may cancel your enrollment at any time. No credits will be offered if you do not complete all required steps of this activity which include registration, watching the recorded content, and completion of pre & post tests as well as course evaluations.
Refund Policy
This activity is free for all healthcare providers who are not employees of an ineligible entity.
No refunds will be issued if you have started watching the recorded content.